Cargando…

267 Dalbavancin for the treatment of Streptococcal Skin Infections

Detalles Bibliográficos
Autores principales:	Puttagunta, Sailaja, Dunne, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781652/ http://dx.doi.org/10.1093/ofid/ofu052.133

Ejemplares similares

266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

398 Pharmacokinetics of dalbavancin (DAL) in bone and associated tissues in patients undergoing orthopedic surgical procedures
por: Baldassarre, James, et al.
Publicado: (2014)

1718 Resistance among Invasive Group A Streptococcal Infections, United States, 1999-2012
por: Van Beneden, Chris, et al.
Publicado: (2014)

Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies
por: Dunne, Michael W., et al.
Publicado: (2015)

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs
por: Gonzalez, Pedro Luis, et al.
Publicado: (2018)

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection
por: Dunne, Michael W., et al.
Publicado: (2016)

1337 Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Non-Pregnant Adults
por: Pitts, Samantha, et al.
Publicado: (2014)

678 Ceftaroline vs Vancomycin in Treatment for Skin and Soft Tissue Infections (SSTI) in Obese Patients
por: Nguyen, Hao, et al.
Publicado: (2014)

679 Ceftaroline Fosamil (CPT-F) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients
por: Kaye, Keith, et al.
Publicado: (2014)

674 Comparison of the Microbiology and Antibiotic Treatment between Diabetic and Non-Diabetic Patients Hospitalized with Acute Bacterial Skin and Skin Structure Infection
por: Jenkins, Timothy, et al.
Publicado: (2014)

680 Predictors of Recurrent Staphylococcus aureus Skin Infection After Treatment: Host, Behavioral, and Pathogen Level Factors
por: Miller, Loren, et al.
Publicado: (2014)

682 Microbiology and Antibiotic Treatment among Injection Drug Users and Non-Injection Drug Users Hospitalized with Acute Bacterial Skin and Skin Structure Infection
por: Jenkins, Timothy, et al.
Publicado: (2014)

1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
por: Corey, Ralph, et al.
Publicado: (2014)

282 Epidemiology of Skin and Soft-Tissue Infections in US Army Trainees at Fort Benning
por: Ellis, Michael, et al.
Publicado: (2014)

413 In Vitro Activity of Tigecycline against Commonly-Isolated Pathogens of Skin and Skin Structure Infections in the United States – TEST 2011-2013
por: Hackel, Meredith, et al.
Publicado: (2014)

470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)
por: Mendes, Rodrigo E., et al.
Publicado: (2014)

262 Effect of NSAID/Corticosteroid Use on the Efficacy of Tedizolid in Acute Bacterial Skin and Skin Structure Infections: Pooled Data From the Phase 3 ESTABLISH-1 and ESTABLISH-2 Studies
por: Sandison, Taylor, et al.
Publicado: (2014)

Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies
por: Dunne, Michael W, et al.
Publicado: (2015)

165 Integrating a Rapid Diagnostic Test and Antimicrobial Stewardship: Optimizing Discharge Antibiotics in Skin and Soft Tissue Infections (SSTI)
por: Yu, Diana, et al.
Publicado: (2014)

366 The Impact of Bathing Hospitalized Dependent Patients with Disposable Washcloths Instead of Traditional Bath Basins on Infection Rates and Skin Condition
por: Haider, Samran, et al.
Publicado: (2014)

691 Rifampin in the Treatment of Staphylococcal Prosthetic Joint Infections
por: Parsaei, Shadi, et al.
Publicado: (2014)

466 Skin lesions in febrile neutropenic patients
por: Yemisen, Mucahit, et al.
Publicado: (2014)

281 Regional Changes in Methicillin-Resistant Staphylococcus aureus in Purulent Skin and Soft Tissue Infections among Patients Presenting to Canadian Emergency Departments
por: Ng, Wil, et al.
Publicado: (2014)

692 Prognostic Value of Inflammatory Markers during Treatment of Prosthetic Joint Infections
por: Manchanda, Upasna, et al.
Publicado: (2014)

284 Risk Factors for Methicillin Resistant Staphylococcus aureus Skin and Soft Tissue Infections in Patients Found to be Colonized When Admitted to an Acute Care Hospital
por: Richardson, Andrea, et al.
Publicado: (2014)

412 In vitro Activity of Key Antimicrobial Agents Against Bacterial Isolates From Intra-abdominal (IAI) and Skin and Wound (SW) Infections: Europe 2004-2013
por: Hoban, Daryl, et al.
Publicado: (2014)

731 Utility of Ceftaroline in the Treatment of Persistent Bacteremia and Deep-Seated Infections
por: Burgess, Donna R., et al.
Publicado: (2014)

1660 Risk of Recurrent Clostridium difficile Infection: Impact of Diagnostics and Treatment
por: Reddy, Sujan C., et al.
Publicado: (2014)

1294 Skin Microbiota Contamination Causes False Positive QuantiFERON-TB Results
por: Gaur, Rajiv
Publicado: (2014)

1045 Linezolid Compared to Daptomycin for the Treatment of Vancomycin-resistant Enterococcal Urinary Tract Infections
por: Moenster, Ryan P., et al.
Publicado: (2014)

291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients
por: Chaftari, Anne-Marie, et al.
Publicado: (2014)

973 Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients
por: Stevens, Vanessa, et al.
Publicado: (2014)

487 Infections Caused by Enterobacteriaceae Species following Cardiac Surgery: Impact of Polymyxin Resistance on Treatment Outcomes
por: Abboud, Cely Saad, et al.
Publicado: (2014)

490 High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
por: Sam, Sharon, et al.
Publicado: (2014)

1655 Lack of Adherence to SHEA-IDSA Treatment Guidelines for Severe Clostridium difficile Infection is Associated with Increased Mortality
por: Patel, Ishan, et al.
Publicado: (2014)

Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials
por: Gonzalez, Pedro L., et al.
Publicado: (2021)

148 Use of a Skin and Soft Tissue Protocol to Reduce Emergency Department use of Ertapenem in a 325 Bed Community Hospital
por: Waters, Dustin, et al.
Publicado: (2014)

1652 Retrospective Comparision of Oral Vancomycin Capsules vs Oral Vancomycin Solution for the Treatment of Severe Clostridium Defficile Infection
por: Saleh, Rania, et al.
Publicado: (2014)

1562 The Influence of Co-infection with HCV on CD4 and B-cell Reconstitution in Human Immunodeficiency Virus (HIV)-infected Patients
por: Abers, Michael S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d6n0c9fqhi8ugcvdvuo2en7opd